| Literature DB >> 27064442 |
Marco Lorenzi1, Ivor J Simpson1, Alex F Mendelson1, Sjoerd B Vos1,2, M Jorge Cardoso1, Marc Modat1, Jonathan M Schott3, Sebastien Ourselin1.
Abstract
The joint analysis of brain atrophy measured with magnetic resonance imaging (MRI) and hypometabolism measured with positron emission tomography with fluorodeoxyglucose (FDG-PET) is of primary importance in developing models of pathological changes in Alzheimer's disease (AD). Most of the current multimodal analyses in AD assume a local (spatially overlapping) relationship between MR and FDG-PET intensities. However, it is well known that atrophy and hypometabolism are prominent in different anatomical areas. The aim of this work is to describe the relationship between atrophy and hypometabolism by means of a data-driven statistical model of non-overlapping intensity correlations. For this purpose, FDG-PET and MRI signals are jointly analyzed through a computationally tractable formulation of partial least squares regression (PLSR). The PLSR model is estimated and validated on a large clinical cohort of 1049 individuals from the ADNI dataset. Results show that the proposed non-local analysis outperforms classical local approaches in terms of predictive accuracy while providing a plausible description of disease dynamics: early AD is characterised by non-overlapping temporal atrophy and temporo-parietal hypometabolism, while the later disease stages show overlapping brain atrophy and hypometabolism spread in temporal, parietal and cortical areas.Entities:
Mesh:
Year: 2016 PMID: 27064442 PMCID: PMC4827392 DOI: 10.1038/srep22161
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baseline socio-demographical and clinical information of the cohort of this study.
| N | 274 | 453 | 154 | 168 |
| age (years) | 74.1 (5.98) | 72.16 (7.55) | 73.21 (7.37) | 75.66 (7.66) |
| sex (% females) | 48 | 42 | 41 | 42 |
| education (years) | 16.22 (2.77) | 16.01 (2.73) | 16.03 (2.67) | 15.1 (3.08) |
| MMSE | 28.98 (1.21) | 28.11 (1.66) | 27.02 (1.75) | 23.05 (2.1) |
The entries for age, education and MMSE indicate group-wise mean and standard deviation in parenthesis. MMSE: mini mental state exam.
Figure 1Flowchart of the cross-validation scheme of a single repeat in the proposed experimental setting.
Figure 2Mean absolute prediction error of PLSR and PM (240 training samples, and leave-one-out -Loo-).
PLSR provides higher predictive accuracy than the local patch based (PM) approach. Results are similar when considering the MCI group (not shown).
| Whole cohort* | 0.31 (0.25,0.38) | 0.21 (0.14, 0.27) | AD vs HC * | 1.07 | 0.79 |
| AD and HC* | 0.33 (0.22, 0.43) | 0.23 (0.12, 0.34) | MCIc vs MCIs | 0.53 | 0.37 |
| MCIc and MCIs* | 0.30 (0.22, 0.38) | 0.20 (0.12, 0.28) | MCIc vs HC* | 0.67 | 0.46 |
A. Correlation (mean, 95% confidence interval) between predicted average regional FDG-PET and the corresponding SUVR values reported in ADNI. B. Effect size between the measures obtained with PLSR and with PM. HC: healthy controls, MCIc: MCI converted to AD, MCIs: MCI stable. (* for significant differences, p < 0.05, paired t-test).
Figure 3Left: reproducibility of the discriminative components.
When comparing AD and controls, component 1 was the only one 100% reproducible and discriminative across repeats. The same consideration applies to component 3 when comparing stable and converting MCI. Right: component 1 describes the relationship between atrophy and FDG-PET uptake spread in temporal, parietal and posterior regions. We also note the partial volume effect in the ventricles for the FDG component. Component 3 shows the non-overlapping spatial inverse relationship between increased expansion of the CSF (ventricles and brain sulci), and joint increased temporal atrophy and cortical hypometabolism.
Figure 4PLSR networks of joint relationship between atrophy and hypometabolism derived from Component 1 and Component 3.
Red hubs indicate regions of joint within- and between-modality correlation. Blue hubs indicate anticorrelated regions (CSF expansion measured in T1-MR). BA = Broadmann anatomical areas.